Share Your Research, Maximize Your Social Impacts
HEPATITE AUTO-IMMUNE : QUELLE PRISE EN CHARGE EN 2024 ?
Journal: International Journal of Advanced Research (Vol.13, No. 03)Publication Date: 2025-03-20
Authors : Maryame El Khayari A. Ibrahimi M. Elabkari; H. Abid;
Page : 1228-1234
Keywords : ;
Source : Download
Find it from : Google Scholar
Abstract
Les hepatites auto-immunes representent un groupe heterogene des maladies inflammatoires du foie rare, grave complexe et hereditaire avec nette predominance feminine. Evolue par poussees entrecoupees de periodes de remissions, La physiopathologie reste encore inconnue et sa classification demeure debattue. Lediagnosticpositif est difficile repose sur des arguments
Other Latest Articles
- ACUTE ESOPHAGEAL NECROSIS : A RARE CONDITION CASE REPORT
- CONTENTS
- COVER
- Cross-Environment Deployment Strategies for Power Platform Solutions β Investigating best practices for managing multi-environment deployments, from development to production, using managed environments and DevOps
- Hyperautomation with Power Platform: Merging AI, RPA, and Low-Code for Business Efficiency β Exploring how AI Builder, Power Automate, and Dataverse can drive end-to-end enterprise automation
Last modified: 2025-04-28 18:06:01